{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-047145","form_type":"8-K","ticker":"TELO","cik":"0001971532","company_name":"Telomir Pharmaceuticals, Inc.","filed_at":"2024-11-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.468288+00:00","generated_at":"2026-05-29T21:20:32.068395+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Telomir Pharma announces resignation of director Michael Jerman; replaces audit committee roles","bullets":["On November 18, 2024, Michael Jerman resigned from the Board and as Chair of the Audit Committee, effective immediately, to pursue other activities, not due to a disagreement.","On November 20, 2024, the Board appointed Dr. Matthew Del Giudice to the Audit Committee to fill the vacancy.","The Board also appointed Matthew Pratt Whalen as Chairman of the Audit Committee.","No exhibits other than the Fifth Refinancing Amendment (not attached here) were filed."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-047145","json":"https://secwatch.observer/filing/0001493152-24-047145.json","markdown":"https://secwatch.observer/filing/0001493152-24-047145.md","text":"https://secwatch.observer/filing/0001493152-24-047145.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1971532/000149315224047145/0001493152-24-047145-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1971532/000149315224047145/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T21:20:32.068395+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d179c7e5cf","claim":"Michael Jerman resigned as Member of the Board of Directors and Chair of the Audit Committee at Telomir Pharmaceuticals, Inc..","evidence_excerpt":"On November 18, 2024, Telomir Pharmaceuticals, Inc. (the “ Company ”) received written notice of resignation from Michael Jerman resigning, with immediate effect, from his positions a member of the Board of Directors of the Company (the “ Board ”) and as Chair of the Audit Committee","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1971532/000149315224047145/0001493152-24-047145-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Member of the Board of Directors and Chair of the Audit Committee"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}